Progyny (PGNY) – New Partner – January 20, 2024

By Brad FreemanJanuary 21, 2024Posted in Stock Insights

Third-Party Content. Provided for informational purposes only. Not investment advice or a recommendation to buy or sell any security. See disclosure here.

Progyny (PGNY) – New Partner – January 20, 2024

Progyny added Vistia Health to its network of preferred partners including Blue Cross Blue Shield. Vistia generated $77.5 million in revenue for its most recent year, making it a smaller win vs. Blue Cross and others. Still, Progyny will now be the preferred partner for all of its employer clients seeking fertility benefits for their team. Partnerships like this will add up over time and will make Progyny’s go-to-market even more efficient than it already is.

Source: YCharts

Disclaimer: Third party content is provided for informational purposes only and should not be construed as an offer to sell or a solicitation of an offer to buy or sell any security. Third party content is not intended to serve as a recommendation to buy or sell any security and is not intended to serve as investment advice. Third party content creators are not affiliated with BBAE Holdings LLC, (“BBAE”) Redbridge Securities LLC (“Redbridge Securities”) or BBAE Advisors LLC (“BBAE Advisors”). All investments involve risk, including the possibility of total loss of principal. For additional important information, please click here.

Meet the Author

Brad Freeman

Stock Market Nerd, BBAE Contributor

Meet Brad Freeman, an independent financial analyst on the BBAE blog, and publisher of the popular StockMarketNerd newsletter. He's known for his thorough, candid takes on many of the most widely-held stocks’ earnings reports — and some less-known companies that Brad feels hold promise. When this University of Michigan finance grad isn't sharing his financial wisdom with his readers, he passionately supports his hometown Detroit sports teams. Keep an eye out for Brad's market analysis and insights.

Read more about Brad Freeman (StockMarketNerd)

Don't miss the next article!

Sign up for the BBAE newsletter to get a front-row seat to the latest investment trends, expert analyses, and educational resources.